Forte Biosciences, Inc. (NasdaqGM: FBRX)
Health Care · Biotechnology · US
$—
— today · — 1Y
Forte Biosciences, Inc. (NasdaqGM: FBRX) operates in the Biotechnology industry within the Health Care sector.
trading between 10.30 and 77.20.
Tweenvest scores Forte Biosciences, Inc. across four factors: quality 35/100, value 90/100. Its strongest factor is value.
FBRX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- —
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -4.55
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- $77.20
- 52-week low
- $10.30
- Avg volume (3M)
- —
- Shares outstanding
- —
- Employees
- 23
- Next earnings
- —
About Forte Biosciences, Inc.
Forte Biosciences, Inc. is a U.S.-based biopharmaceutical company currently in its clinical development phase. The firm's key initiative involves advancing the FB-102 program, which is designed to tackle a variety of autoimmune conditions, notably vitiligo and alopecia areata. Their main offices are situated in Dallas, Texas.
- ISIN
- US34962G2084
- Listed since
- Apr 13, 2017
- Exchange
- Nasdaq Global Market
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Anthera Pharmaceuticals, Inc.OTCPK: ANTH | $26.00 | $— | — |
| Evelo Biosciences, Inc.OTCPK: EVLO | $19.00 | $— | — |
| IMV Inc.OTCPK: IMVI.F | $15.00 | $— | — |
| PhaseRx, Inc.OTCPK: PZRX.Q | $12.00 | $— | — |
| ContraFect CorporationOTCPK: CFRX.Q | $11.00 | $0.00 | — |
| Notable Labs, Ltd.OTCPK: NTBL.Q | $10.00 | $— | — |
| OncoSec Medical IncorporatedOTCPK: ONCS.Q | $6.00 | $— | — |
| Kiromic BioPharma, Inc.OTCPK: KRBP.Q | $2.00 | $0.00 | — |
Figures last refreshed Sep 20, 2026.